Jiangsu Sinopep-Allsino Biopharmaceutical Co Ltd Sustainability Reports
The company engages in the independent research and development, customized development, and commercial production of peptide drugs, oligonucleotides, and small molecule drugs. Its operations focus on treating diabetes, cardiovascular diseases, tumors, and other major clinical therapeutic areas.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00VJTQW71
2 reports from 2024 to 2025
